BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhou Q, Zhu LL, Yan XF, Pan WS, Zeng S. Drug utilization of clarithromycin for gastrointestinal disease treatment. World J Gastroenterol 2008; 14(39): 6065-6071 [PMID: 18932287 DOI: 10.3748/wjg.14.6065]
URL: https://www.wjgnet.com/1007-9327/full/v14/i39/6065.htm
Number Citing Articles
1
Giannoula S Tansarli, Petros I Rafailidis, Anastasios Kapaskelis, Matthew E Falagas. Frequency of the off-label use of antibiotics in clinical practice: a systematic reviewExpert Review of Anti-infective Therapy 2012; 10(12): 1383 doi: 10.1586/eri.12.137
2
Bingyun Lu, Jiamin Wang, Jing Li, Le Liu, Ye Chen. Half‐dose clarithromycin‐containing bismuth quadruple therapy is effective and economical in treating Helicobacter pylori infection: A single‐center, open‐label, randomized trial Helicobacter 2019; 24(2): e12566 doi: 10.1111/hel.12566